The plant in Kabul, Afghanistan, is proving to be a key participant in the global supply market for Abacavir Sulphate drug substance. This local manufacturing ability represents a considerable step forward for the Afghan pharmaceutical industry and provides a distinct opportunity to reduce need on imports. The production of this vital HIV compound